Advertisement

Prognosis in the Rheumatic Diseases

  • Nicholas Bellamy

Table of contents

  1. Front Matter
    Pages i-xiii
  2. J. F. Fries, N. Bellamy
    Pages 1-10
  3. K. D. Brandt, D. Flusser
    Pages 11-35
  4. F. Wolfe
    Pages 37-82
  5. B. M. Ansell
    Pages 83-96
  6. B. T. Emmerson
    Pages 97-131
  7. P. S. Helliwell, V. Wright
    Pages 133-152
  8. D. D. Gladman
    Pages 153-166
  9. W. F. Kean, D. W. MacPherson
    Pages 167-192
  10. R. Roubenoff, M. C. Hochberg
    Pages 193-212
  11. V. D. Steen, T. A. Medsger
    Pages 213-231
  12. C. V. Oddis, T. A. Medsger
    Pages 233-249
  13. F. J. Barbado, J. J. Vázquez, M. Khamashta, G. R. V. Hughes
    Pages 251-267
  14. N. Bellamy, R. R. Grigor, R. P. Naden
    Pages 279-319
  15. F. Wolfe
    Pages 321-332
  16. I. K. Y. Tsang
    Pages 333-345
  17. W. W. Buchanan, P. M. Brooks
    Pages 403-450
  18. Back Matter
    Pages 493-502

About this book

Introduction

Seer, forecaster, prophet, geomancer, or tout - all predict future events as physicians must. The medical activity is prognosis from the Greek pro (forward) and gnosis (special knowledgeL thus foreknowledge, and the practitioner is the prognosticator, a sobriquet which falls unhappily upon the ear. Like it or not, there is nothing more critical in the management of chronic rheumatic conditions than a reasonably clear picture of what time and disease will bring. The knowledge is so much a part of ordinary medical thinking that we rarely grace it with the label prognosis. But, like so much of "ordinary medical thinking" (an oxymoron, perhaps), quantitative data are very thin and the chestnuts of personal observation and authority figure assertion loom large. Unlike several books I have seen or written, this one on prognosis needs no justification. The entirety of a person's life contributes to and confounds what the future holds. The ingredients include education levet income, support structures such as family, housing, occupation, availability of medical services, diagnosis, treatment, rate of disease progression, age, gender, race, marital status, and others too numerous to mention or too arcane to be recognized. One would think the task of estimating prognosis impossible. And yet there is light on the horizon -we do know a few things such as the effect of high rheumatoid factor titers on the prognosis of RA or the likely outcome of certain kidney lesions in SLE.

Keywords

rheumatic diseases

Editors and affiliations

  • Nicholas Bellamy
    • 1
    • 2
  1. 1.University of Western OntarioLondonCanada
  2. 2.Division of RheumatologyVictoria HospitalLondonCanada

Bibliographic information